Dyne Therapeutics, Inc. (DYN) Ownership

$12.24

$0.62 (5.34%)
Last update: 04:00 PM EST
Day's range
$11.64
Day's range
$12.6

Dyne Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 05/15/2025 10.35 M $118.47 M   40.30% 9.42%
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 9.71 M $101.61 M   52.24% 8.84%
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 05/14/2025 9.13 M $95.50 M   13.86% 8.31%
BLACKROCK, INC. 05/02/2025 8.05 M $84.17 M   1.23% 7.32%
VANGUARD GROUP INC 05/09/2025 7.41 M $77.47 M   10.48% 6.74%
FCPM III SERVICES B.V. 05/15/2025 5.46 M $57.14 M   0.00% 4.97%
FMR LLC 05/12/2025 5.20 M $54.34 M   -35.03% 4.73%
BRAIDWELL LP 05/15/2025 3.62 M $37.88 M   431.63% 3.29%
STATE STREET CORP 05/15/2025 3.61 M $37.76 M   -2.90% 3.28%
CITADEL ADVISORS LLC 05/15/2025 3.01 M $31.48 M   5.17% 2.74%
ARMISTICE CAPITAL, LLC 05/15/2025 2.77 M $28.95 M   186.98% 2.52%
SIREN, L.L.C. 05/23/2025 2.72 M $28.43 M   101.71% 2.47%
TCG CROSSOVER MANAGEMENT, LLC 05/14/2025 2.65 M $27.72 M   0.00% 2.41%
JPMORGAN CHASE & CO 05/12/2025 2.53 M $26.48 M   2,472.81% 2.30%
PERCEPTIVE ADVISORS LLC 08/06/2025 2.31 M $24.20 M   325.82% 2.10%
VR ADVISER, LLC 05/15/2025 2.17 M $22.74 M   0.00% 1.98%
DEEP TRACK CAPITAL, LP 05/15/2025 2.00 M $20.92 M   0.00% 1.82%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.96 M $20.46 M   3.61% 1.78%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 1.82 M $19.04 M   -24.23% 1.66%
VESTAL POINT CAPITAL, LP 05/15/2025 1.80 M $18.83 M   100.00% 1.64%
RTW INVESTMENTS, LP 05/15/2025 1.69 M $17.68 M   -67.61% 1.54%
POINT72 ASSET MANAGEMENT, L.P. 07/21/2025 1.53 M $15.99 M   65.30% 1.39%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2025 1.44 M $15.10 M   100.00% 1.31%
FRANKLIN RESOURCES INC 05/13/2025 1.41 M $14.80 M   6.88% 1.29%
MORGAN STANLEY 05/15/2025 1.39 M $14.56 M   84.66% 1.27%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 05/15/2025 1.39 M $14.52 M   1,066.60% 1.26%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/14/2025 1.17 M $12.22 M   100.00% 1.06%
VIVO CAPITAL, LLC 05/12/2025 1.11 M $11.66 M   0.00% 1.01%
ORBIMED ADVISORS LLC 05/15/2025 1.01 M $10.61 M   -17.32% 0.92%
GOLDMAN SACHS GROUP INC 06/27/2025 994.89 K $10.41 M   58.24% 0.91%
ARROWMARK COLORADO HOLDINGS LLC 05/15/2025 897.95 K $9.39 M   -3.68% 0.82%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2025 812.41 K $8.50 M   86.48% 0.74%
NORTHERN TRUST CORP 05/13/2025 722.46 K $7.56 M   -7.02% 0.66%
SOFINNOVA INVESTMENTS, INC. 05/15/2025 716.90 K $7.50 M   -33.09% 0.65%
MPM ASSET MANAGEMENT LLC 05/15/2025 682.38 K $7.14 M   0.00% 0.62%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 680.84 K $7.12 M   154.64% 0.62%
BAKER BROS. ADVISORS LP 05/15/2025 672.10 K $7.03 M   0.00% 0.61%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 654.13 K $6.84 M   -2.00% 0.60%
WOODLINE PARTNERS LP 05/15/2025 574.44 K $6.01 M   0.08% 0.52%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2025 524.50 K $5.49 M   10.53% 0.48%
WASATCH ADVISORS LP 05/15/2025 511.05 K $5.35 M   59.39% 0.47%
LOGOS GLOBAL MANAGEMENT LP 05/15/2025 500.00 K $5.23 M   11.11% 0.45%
ALGERT GLOBAL LLC 05/13/2025 476.01 K $4.98 M   488.22% 0.43%
CANDRIAM S.C.A. 05/14/2025 463.37 K $4.85 M   15.44% 0.42%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2025 450.00 K $4.71 M   200.00% 0.41%
SG AMERICAS SECURITIES, LLC 04/15/2025 430.05 K $4.50 M   2,159.15% 0.39%
IKARIAN CAPITAL, LLC 05/15/2025 358.84 K $3.75 M   100.00% 0.33%
UBS GROUP AG 05/13/2025 357.75 K $3.74 M   -33.76% 0.33%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2025 345.06 K $3.61 M   100.00% 0.31%
TREXQUANT INVESTMENT LP 05/14/2025 334.44 K $3.50 M   166.75% 0.30%

Dyne Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 181 institutional investors and hedge funds held shares of Dyne Therapeutics, Inc.. The most heavily invested institutionals were:

Stephens Consulting, LLC: 0

DIMENSIONAL FUND ADVISORS LP: 0

FOX RUN MANAGEMENT, L.L.C.: 0

Handelsbanken Fonder AB: 0

Larson Financial Group LLC: 0

Corebridge Financial, Inc.: 0

110.86% of Dyne Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 96.51 M shares in the last 24 months. This purchase volume represents approximately $1.18 B in transactions.